scholarly journals Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancer

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Chia-Hao Liu ◽  
Yen-Hsuan Kung ◽  
Jeff Chien-Fu Lin ◽  
Chi-Mu Chuang ◽  
Hua- Hsi Wu ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Therapeutic Effect ◽  
Low Dose ◽  
Recurrent Cervical Cancer

scholarly journals Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases

2018 ◽  
Vol 24 ◽  
pp. 57-60 ◽  
Author(s):  
Rose Isono-Nakata ◽  
Hiroshi Tsubamoto ◽  
Tomoko Ueda ◽  
Kayo Inoue ◽  
Hiroaki Shibahara
Keyword(s):  
Cervical Cancer ◽  
Low Dose ◽  
Metronomic Chemotherapy ◽  
Oral Cyclophosphamide ◽  
Recurrent Cervical Cancer ◽  
Dose Oral

Therapeutic effect of low-dose aspirin on chronic allograft nephropathy in renal recipient rats

2010 ◽  
Vol 30 (6) ◽  
pp. 650-652
Author(s):  
Qi-lei JIA ◽  
Zi-zhen HOU ◽  
Jun-sheng BAO ◽  
Xin-sheng XI ◽  
Zhong-jin YUE
Keyword(s):  
Therapeutic Effect ◽  
Low Dose ◽  
Chronic Allograft Nephropathy ◽  
Dose Aspirin ◽  
Low Dose Aspirin

SURGERY FOR RESIDUAL DISEASE AFTER RADIOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER

2019 ◽  
Vol 65 (5) ◽  
pp. 721-725
Author(s):  
Elmira Shakirova ◽  
Andrey Panov ◽  
Alevtina Akhmetzyanova ◽  
Aliya Gafiullina ◽  
L. Ibragimova ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Residual Disease ◽  
Locally Advanced ◽  
Residual Tumor ◽  
Advanced Cervical Cancer ◽  
Mri Imaging ◽  
Recurrent Cervical Cancer ◽  
Locally Advanced Cervical Cancer ◽  
Visible Effect ◽  
Adjuvant Hysterectomy

Aims: Chemoradiation (CRT) is the standard treatment for locally advanced cervical cancer (LACC). However part of the patients develop recurrence during the first year after treatment despite good visible effect at the first follow-up. The role of completion surgery after radiotherapy (RT) is still debated. A number of papers have showed that up to 60% of patients have residual tumor after CRT and RT. But such a surgery is not widely recommended because of increased morbidity of the treatment. The aim of this study was to assess the results of surgery after radiotherapy of LACC. Method: We retrospectively evaluated data on 86 patients with cervical cancer IB - IIIB stages (mostly stage IIB) who underwent surgery in different modalities after CRT and RT with good clinical response in our department in 2015-2018. Results: When small asymptomatic residual disease was detected early after radiotherapy radical hysterectomy was feasible in most of the cases. Patients with clinical manifestation of recurrence had very poor prognosis. Surgery of recurrent cervical cancer sufficiently deteriorates quality of life, even if possible. Conclusion: Thorough examination with adding MRI imaging after initial treatment of cervical cancer needed to identify patients who may benefit from adjuvant hysterectomy.

scholarly journals The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study

2019 ◽  
Vol Volume 13 ◽  
pp. 3419-3424 ◽  
Author(s):  
Jiangtao Yu ◽  
Ziwen Xu ◽  
Anyang Li ◽  
Jindi Zhang ◽  
Yi Wang ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Retrospective Study ◽  
Efficacy And Safety ◽  
Recurrent Cervical Cancer
Sign in / Sign up

Export Citation Format

Share Document